IBM is working with pharmaceutical, life sciences and broader healthcare clients around the world to help create a profound transformation towards smarter business models and processes within the regulatory environment. Life Sciences companies must transform their business models and underlying R&D processes to integrate biomarker knowledge, embrace a new collaborative model of innovation, and to develop safe and effective patient / consumer centric offerings. From data analysis to clinical trial management to medical imaging and diagnostics, IBM can provide end-to-end solutions and services to help you integrate disparate data sources, automate and streamline research and business processes, share information and collaborate on findings, and facilitate regulatory compliance.

For more information, please visit ibm.com/industries/healthcare

©Copyright Phacilitate Limited 2009

» Click here to suggest a speaker or to contribute to the programs

» Click here to review the Oncology Leaders' Forum speaker panel from the last event

» Click here to review the R&D Leaders' Forum speaker panel from the last event